A unique medium chain triglyceride-containing micronutrient complex: Effects on migraine symptoms compared to quality of lif

Purpose: Migraine headaches and associated symptoms are prevalent medical issues. Medium-chain triglyceride (MCT)/nootropic-based compounds have demonstrated benefits in multiple domains. This study assessed the potential relief provided from a unique, high-concentration MCT/nootropic component blend on migraine frequency, duration, secondary symptoms, quality of life (QOL) during 60-day clinical investigation. Methods: Forty (n=40) chronic sufferers [migraineurs] were prospectively randomized to participate double-blinded study. Both intervention (n=30) control (n=10) participants required maintain lifestyle patterns for trial duration. surveys used electronic response forms allow subjects increased ease safety COVID-19 pandemic. Results. The experienced reduction episodes by 53%, 11.6 5.4 per month, after 60 days supplement use. average episode duration decreased 260 minutes 158 minutes, 39% improvement. Time lost due severe effect was reduced an more than five month just over two decrease 55%. A combined measure which aggregate illustrate intensity, also according subject rating 37%. Self-assessed QOL scales improved 43% cohort. showed no significant changes any measures. Conclusion: Consumption nootropic brain complex significantly including severity, dysfunction. formulation beneficially impacted effects self-reported QOL.